Squamous Cell Carcinoma of the Bladder Is Not Associated With High-risk HPV
Jennifer Gordetsky(Bipar), Soroush Rais‐Bahrami(University of Alabama at Birmingham), Sonia Kamanda(Johns Hopkins University), Michelle S. Hirsch(Perinatal Institute), Lauren E. Schwartz(Hospital of the University of Pennsylvania), Steve Boorjian(Mayo Clinic in Arizona), Brittney A. Imblum(University of Pennsylvania), Éva Compérat(Vienna General Hospital), Michele R. Anderson(Vanderbilt University Medical Center), Giovanna A. Giannico(Henry Ford Health System), Igor Frank(Cleveland Clinic), John C. Cheville(Mayo Clinic), Maria Del Carmen Rodriguez Peña(Memorial Sloan Kettering Cancer Center), Andrew J. Spieker(Vanderbilt University Medical Center), Carlos Prieto‐Granada(Vanderbilt University Medical Center), Kenneth A. Iczkowski(University of California, Davis)
Cited by 11
Related Papers
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines
|European Urology|2020|2.2k
Updated 2016 EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer
|European Urology|2016|1.5k
Classification of renal cell carcinoma
|Cancer|1997|878
Costimulatory B7-H1 in renal cell carcinoma patients: Indicator of tumor aggressiveness and potential therapeutic target
|Proceedings of the National Academy of Sciences|2004|767
The 2019 International Society of Urological Pathology (ISUP) Consensus Conference on Grading of Prostatic Carcinoma
|The American Journal of Surgical Pathology|2020|705